These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19086063)

  • 1. Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029.
    Krivickas LS; Walsh R; Amato AA
    Muscle Nerve; 2009 Jan; 39(1):3-9. PubMed ID: 19086063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SB431542 treatment promotes the hypertrophy of skeletal muscle fibers but decreases specific force.
    Watt KI; Jaspers RT; Atherton P; Smith K; Rennie MJ; Ratkevicius A; Wackerhage H
    Muscle Nerve; 2010 May; 41(5):624-9. PubMed ID: 20151464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C.
    Bogdanovich S; McNally EM; Khurana TS
    Muscle Nerve; 2008 Mar; 37(3):308-16. PubMed ID: 18041051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice.
    Matsakas A; Foster K; Otto A; Macharia R; Elashry MI; Feist S; Graham I; Foster H; Yaworsky P; Walsh F; Dickson G; Patel K
    Neuromuscul Disord; 2009 Jul; 19(7):489-99. PubMed ID: 19541486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of swim taper on whole muscle and single muscle fiber contractile properties.
    Trappe S; Costill D; Thomas R
    Med Sci Sports Exerc; 2001 Jan; 33(1):48-56. PubMed ID: 11194111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do single-fiber studies tell us about exercise training?
    Malisoux L; Francaux M; Theisen D
    Med Sci Sports Exerc; 2007 Jul; 39(7):1051-60. PubMed ID: 17596771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle fiber function and rate of disease progression in amyotrophic lateral sclerosis.
    Krivickas LS; Yang JI; Kim SK; Frontera WR
    Muscle Nerve; 2002 Nov; 26(5):636-43. PubMed ID: 12402285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
    Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
    Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.
    Bartoli M; Poupiot J; Vulin A; Fougerousse F; Arandel L; Daniele N; Roudaut C; Noulet F; Garcia L; Danos O; Richard I
    Gene Ther; 2007 May; 14(9):733-40. PubMed ID: 17330087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decomposition-based quantitative electromyography in the evaluation of muscular dystrophy severity.
    Derry KL; Venance SL; Doherty TJ
    Muscle Nerve; 2012 Apr; 45(4):507-13. PubMed ID: 22431083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of swim taper on whole muscle and single muscle fiber contractile properties.
    Trappe S; Costill D; Thomas R
    Med Sci Sports Exerc; 2000 Dec; 32(12):48-56. PubMed ID: 11224794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.
    Wagner KR; Fleckenstein JL; Amato AA; Barohn RJ; Bushby K; Escolar DM; Flanigan KM; Pestronk A; Tawil R; Wolfe GI; Eagle M; Florence JM; King WM; Pandya S; Straub V; Juneau P; Meyers K; Csimma C; Araujo T; Allen R; Parsons SA; Wozney JM; Lavallie ER; Mendell JR
    Ann Neurol; 2008 May; 63(5):561-71. PubMed ID: 18335515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies].
    Oya Y; Ogawa M; Kawai M
    Rinsho Shinkeigaku; 2001 Oct; 41(10):698-700. PubMed ID: 11993192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ageing and gender on contractile properties in human skeletal muscle and single fibres.
    Yu F; Hedström M; Cristea A; Dalén N; Larsson L
    Acta Physiol (Oxf); 2007 Jul; 190(3):229-41. PubMed ID: 17581136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a preferential myosin loss on Ca2+ activation of force generation in single human skeletal muscle fibres.
    Ochala J; Larsson L
    Exp Physiol; 2008 Apr; 93(4):486-95. PubMed ID: 18245202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myostatin blockade therapy for muscular atrophy].
    Sunada Y
    Brain Nerve; 2011 Nov; 63(11):1271-7. PubMed ID: 22068480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myostatin expression in muscular dystrophies and mitochondrial encephalomyopathies.
    Castro-Gago M; Blanco-Barca MO; Eiris-Puñal J; Carneiro I; Arce VM; Devesa J
    Pediatr Neurol; 2006 Apr; 34(4):281-4. PubMed ID: 16638502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I.
    Løkken N; Hedermann G; Thomsen C; Vissing J
    Ann Neurol; 2016 Sep; 80(3):466-71. PubMed ID: 27463532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy: unusual activation of single fibers in vitro.
    Takagi A; Nonaka I
    Muscle Nerve; 1981; 4(1):10-5. PubMed ID: 7231441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth.
    Nozaki M; Li Y; Zhu J; Ambrosio F; Uehara K; Fu FH; Huard J
    Am J Sports Med; 2008 Dec; 36(12):2354-62. PubMed ID: 18725651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.